Bromelain inhibits SARS-CoV-2 infection via targeting ACE-2, TMPRSS2, and spike protein
| Errataetall: | |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
|---|---|
| Enthalten in: |
Clinical and translational medicine - 11(2021), 2 vom: 16. Feb., Seite e281 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sagar, Satish [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 10.05.2021 Date Revised 30.03.2024 published: Print UpdateOf: bioRxiv. 2020 Sep 16;:. - PMID 32995771 Citation Status MEDLINE |
|---|
| doi: |
10.1002/ctm2.281 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM321931483 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM321931483 | ||
| 003 | DE-627 | ||
| 005 | 20240331000349.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/ctm2.281 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1357.xml |
| 035 | |a (DE-627)NLM321931483 | ||
| 035 | |a (NLM)33635001 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Sagar, Satish |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Bromelain inhibits SARS-CoV-2 infection via targeting ACE-2, TMPRSS2, and spike protein |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 10.05.2021 | ||
| 500 | |a Date Revised 30.03.2024 | ||
| 500 | |a published: Print | ||
| 500 | |a UpdateOf: bioRxiv. 2020 Sep 16;:. - PMID 32995771 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Spike Glycoprotein, Coronavirus |2 NLM | |
| 650 | 7 | |a spike protein, SARS-CoV-2 |2 NLM | |
| 650 | 7 | |a Bromelains |2 NLM | |
| 650 | 7 | |a 9001-00-7 |2 NLM | |
| 650 | 7 | |a ACE2 protein, human |2 NLM | |
| 650 | 7 | |a EC 3.4.17.23 |2 NLM | |
| 650 | 7 | |a Angiotensin-Converting Enzyme 2 |2 NLM | |
| 650 | 7 | |a EC 3.4.17.23 |2 NLM | |
| 650 | 7 | |a Serine Endopeptidases |2 NLM | |
| 650 | 7 | |a EC 3.4.21.- |2 NLM | |
| 650 | 7 | |a TMPRSS2 protein, human |2 NLM | |
| 650 | 7 | |a EC 3.4.21.- |2 NLM | |
| 700 | 1 | |a Rathinavel, Ashok Kumar |e verfasserin |4 aut | |
| 700 | 1 | |a Lutz, William E |e verfasserin |4 aut | |
| 700 | 1 | |a Struble, Lucas R |e verfasserin |4 aut | |
| 700 | 1 | |a Khurana, Surender |e verfasserin |4 aut | |
| 700 | 1 | |a Schnaubelt, Andy T |e verfasserin |4 aut | |
| 700 | 1 | |a Mishra, Nitish Kumar |e verfasserin |4 aut | |
| 700 | 1 | |a Guda, Chittibabu |e verfasserin |4 aut | |
| 700 | 1 | |a Palermo, Nicholas Y |e verfasserin |4 aut | |
| 700 | 1 | |a Broadhurst, Mara J |e verfasserin |4 aut | |
| 700 | 1 | |a Hoffmann, Tobias |e verfasserin |4 aut | |
| 700 | 1 | |a Bayles, Kenneth W |e verfasserin |4 aut | |
| 700 | 1 | |a Reid, St Patrick M |e verfasserin |4 aut | |
| 700 | 1 | |a Borgstahl, Gloria E O |e verfasserin |4 aut | |
| 700 | 1 | |a Radhakrishnan, Prakash |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical and translational medicine |d 2012 |g 11(2021), 2 vom: 16. Feb., Seite e281 |w (DE-627)NLM224642685 |x 2001-1326 |7 nnns |
| 773 | 1 | 8 | |g volume:11 |g year:2021 |g number:2 |g day:16 |g month:02 |g pages:e281 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/ctm2.281 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 11 |j 2021 |e 2 |b 16 |c 02 |h e281 | ||